Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Duensing

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Acta Physiologica (Oxford, England)|March 22, 2024
Knock-out of dipeptidase CN2 in human proximal tubular cells disrupts dipeptide and amino acid homeostasis and para- and transcellular solute transportTilman Pfeffer, Susanne M Krug, Tamara Kracke, et al.
JMIR Medical Informatics|January 20, 2022
A Platform and Multisided Market for Translational, Software-Defined Medical Procedures in the Operating Room (OP 4.1): Proof-of-Concept StudyMagdalena Görtz, Michael Byczkowski, Mathias Rath, et al.
Scientific Reports|May 12, 2018
Genomic features of renal cell carcinoma with venous tumor thrombusGregor Warsow, Daniel Hübschmann, Kortine Kleinheinz, et al.
Urologia Internationalis|June 22, 2023
Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell CarcinomaMarie Mikuteit, Stefanie Zschäbitz, Christine Stöhr, et al.
Nature Communications|June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityRouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
Discover Oncology|September 22, 2022
Expression of nectin-4 in papillary renal cell carcinomaStefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, et al.
Scientific Reports|November 14, 2018
Correlation between genomic index lesions and mpMRI and <sup>68</sup>Ga-PSMA-PET/CT imaging features in primary prostate cancerClaudia Kesch, Jan-Philipp Radtke, Axel Wintsche, et al.
Urologic Oncology|July 30, 2021
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancerCathleen Nientiedt, Jan Budczies, Volker Endris, et al.
Urologic Oncology|April 14, 2020
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panelCathleen Nientiedt, Volker Endris, Maximilian Jenzer, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Acta Physiologica (Oxford, England)|March 22, 2024
Knock-out of dipeptidase CN2 in human proximal tubular cells disrupts dipeptide and amino acid homeostasis and para- and transcellular solute transportTilman Pfeffer, Susanne M Krug, Tamara Kracke, et al.
JMIR Medical Informatics|January 20, 2022
A Platform and Multisided Market for Translational, Software-Defined Medical Procedures in the Operating Room (OP 4.1): Proof-of-Concept StudyMagdalena Görtz, Michael Byczkowski, Mathias Rath, et al.
Scientific Reports|May 12, 2018
Genomic features of renal cell carcinoma with venous tumor thrombusGregor Warsow, Daniel Hübschmann, Kortine Kleinheinz, et al.
Urologia Internationalis|June 22, 2023
Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell CarcinomaMarie Mikuteit, Stefanie Zschäbitz, Christine Stöhr, et al.
Nature Communications|June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityRouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
Discover Oncology|September 22, 2022
Expression of nectin-4 in papillary renal cell carcinomaStefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, et al.
Scientific Reports|November 14, 2018
Correlation between genomic index lesions and mpMRI and <sup>68</sup>Ga-PSMA-PET/CT imaging features in primary prostate cancerClaudia Kesch, Jan-Philipp Radtke, Axel Wintsche, et al.
Urologic Oncology|July 30, 2021
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancerCathleen Nientiedt, Jan Budczies, Volker Endris, et al.
Urologic Oncology|April 14, 2020
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panelCathleen Nientiedt, Volker Endris, Maximilian Jenzer, et al.
Pageof 14